Xenetic Biosciences (XBIO) Q4 2024 Annual Earnings
XBIO·Reported May 13, 2025
Xenetic Biosciences reported Q4 2024 revenue of $648.8K. Diluted EPS came in at $-0.68.
Revenue
$648.8K
Diluted EPS
$-0.68
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Xenetic Biosciences's Q4 2024 earnings report.
Xenetic Biosciences (XBIO) reported Q4 2024 earnings on May 13, 2025.
Xenetic Biosciences reported revenue of $648.8K and diluted EPS of $-0.68 for Q4 2024.
You can read the 10-K periodic report (0001683168-25-001686) directly on SEC EDGAR. The filing index links above go to sec.gov.